Generics 11

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Polymyxin b manufacturers

11 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

11 products found

polymyxin b

Vials, injection 500 000 Units USP/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #11531

Manufacturer usually replies in 6 days

polymyxin b

Solution for injection 5000000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

polymyxin b

Solution for injection/infusion 5 LU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

polymyxin b + bacitracin + neomycin sulfate

Cream 5000 units, 400 units, 3400 units

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17459

Manufacturer usually replies in 15 days

polymyxin b

Vials, lyophilized 500000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #33693

Manufacturer usually replies in nan days

neomycin + polymyxin b + bacitracin

Oral powder 3400 IU + 5000 IU + 400 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

chloramphenicol + polymyxin b + dexamethasone

Cutaneous ointment 4 mg + 5000 IU + 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

chloramphenicol + polymyxin b + phenylmercuric

Ear/eye drops 1.0% w/v+5000 IU+0.001% w/v, 5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18647

Manufacturer usually replies in 8 days

chloramphenicol + polymyxin b + loteprednol etabonate

Eye drops 0.4% w/v + 5000 IU + 0.5% w/v, 0.4% w/v + 5000 IU + 0.1% w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO
Manufacturer #18135

Manufacturer usually replies in 12 days

chloramphenicol + polymyxin b + dexamethasone

Eye ointment 10 mg + 100000 IU + 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18351

dexamethasone + neomycin + polymyxin b

Eye drops 1 mg + 3.5 mg + 6000 IU/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

Polymyxin B is an antibiotic used to treat bacterial infections, such as meningitis, pneumonia, sepsis. Although manufacturing companies use polymyxin B as a standalone drug, it is more commonly used in combination drug formulations, along with other active ingredients such as lidocaine, neomycin, bacitracin, diperodon, hydrocortisone, as well as many others. Polymyxin B suppliers market the standalone medication in the form of powders for injectable solutions. In medical use for over 50 years, polymyxin B has since become included in the WHO’s list of Essential Medicines that contains the most important drugs recommended for a basic health system. Polymyxin B suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified polymyxin B manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.